Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,490
Closed -$2.06M 539
2021
Q4
$2.06M Hold
9,490
0.02% 245
2021
Q3
$1.8M Sell
9,490
-628,666
-99% -$115M 0.01% 245
2021
Q2
$113M Buy
638,156
+10,150
+2% +$1.75M 1.03% 35
2021
Q1
$103M Sell
628,006
-195,014
-24% -$29.8M 1.01% 36
2020
Q4
$115M Sell
823,020
-3,791
-0.5% -$478K 1.2% 25
2020
Q3
$92.4M Sell
826,811
-250,476
-23% -$29M 1.13% 32
2020
Q2
$100M Sell
1,077,287
-17,005
-2% -$1.45M 1.37% 17
2020
Q1
$80.3M Sell
1,094,292
-183,774
-14% -$16M 1.37% 20
2019
Q4
$107M Buy
1,278,066
+20,663
+2% +$1.6M 1.41% 15
2019
Q3
$106M Sell
1,257,403
-279,193
-18% -$21.1M 1.38% 18
2019
Q2
$88.2M Buy
1,536,596
+54,267
+4% +$3.13M 1.23% 17
2019
Q1
$87.4M Sell
1,482,329
-111,058
-7% -$6.63M 1.2% 25
2018
Q4
$73.3M Buy
1,593,387
+1,577,640
+10,019% +$86.6M 1.17% 24
2018
Q3
$943K Sell
15,747
-7,761
-33% -$425K 0.01% 299
2018
Q2
$1.01M Buy
23,508
+785
+3% +$31.7K 0.01% 299
2018
Q1
$793K Hold
22,723
0.01% 347
2017
Q4
$824K Buy
+22,723
New +$796K 0.01% 319

Other funds holding MEDP

Pendal Group's MEDP Position: Q1 2022 in Review

Pendal Group sold out of Medpace (MEDP) in Q1 2022, closing a stake of 9,490 shares — an estimated $2.06M sold.

Pendal Group first reported a position in MEDP in Q4 2017 and held it in 17 quarters. The position peaked at $115M in Q4 2020. 349 funds tracked by Wall St. Rank hold MEDP as of Q1 2022.

  • Pendal Group reported no remaining Medpace position as of Q1 2022 after selling out during the quarter.
  • Pendal Group sold 9,490 Medpace shares in Q1 2022, an estimated $2.06M.
  • Pendal Group first reported a position in Medpace in Q4 2017 and held it in 17 quarters.
  • Pendal Group's Medpace position peaked at $115M in Q4 2020.
  • 349 funds tracked by Wall St. Rank held Medpace as of Q1 2022.

Based on Pendal Group's 13F filing for Q1 2022, filed 25 Apr 2022.